1. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study
- Author
-
Lo, SW, Gladstone, RA, van Tonder, AJ, Lees, JA, du Plessis, M, Benisty, R, Givon-Lavi, N, Hawkins, PA, Cornick, JE, Kwambana-Adams, B, Law, PY, Ho, PL, Antonio, M, Everett, DB, Dagan, R, von Gottberg, A, Klugman, KP, McGee, L, Breiman, RF, Bentley, SD, Brooks, AW, Corso, A, Davydov, A, Maguire, A, Pollard, A, Kiran, A, Skoczynska, A, Moiane, B, Beall, B, Sigauque, B, Aanensen, D, Lehmann, D, Faccone, D, Foster-Nyarko, E, Bojang, E, Egorova, E, Voropaeva, E, Sampane-Donkor, E, Sadowy, E, Bigogo, G, Mucavele, H, Belabbès, H, Diawara, I, Moïsi, J, Verani, J, Keenan, J, Nair Thulasee Bhai, JN, Ndlangisa, KM, Zerouali, K, Ravikumar, KL, Titov, L, De Gouveia, L, Alaerts, M, Ip, M, de Cunto Brandileone, MC, Hasanuzzaman, M, Paragi, M, Nurse-Lucas, M, Ali, M, Elmdaghri, N, Croucher, N, Wolter, N, Porat, N, Köseoglu Eser, Ö, Akpaka, PE, Turner, P, Gagetti, P, Tientcheu, PE, Carter, PE, Mostowy, R, Kandasamy, R, Ford, R, Henderson, R, Malaker, R, Shakoor, S, Grassi Almeida, SC, Saha, SK, Doiphode, S, Madhi, SA, Devi Sekaran, S, Srifuengfung, S, Obaro, S, Clarke, SC, Nzenze, SA, Kastrin, T, Ochoa, TJ, Balaji, V, Hryniewicz, W, Urban, Y, Lo, SW, Gladstone, RA, van Tonder, AJ, Lees, JA, du Plessis, M, Benisty, R, Givon-Lavi, N, Hawkins, PA, Cornick, JE, Kwambana-Adams, B, Law, PY, Ho, PL, Antonio, M, Everett, DB, Dagan, R, von Gottberg, A, Klugman, KP, McGee, L, Breiman, RF, Bentley, SD, Brooks, AW, Corso, A, Davydov, A, Maguire, A, Pollard, A, Kiran, A, Skoczynska, A, Moiane, B, Beall, B, Sigauque, B, Aanensen, D, Lehmann, D, Faccone, D, Foster-Nyarko, E, Bojang, E, Egorova, E, Voropaeva, E, Sampane-Donkor, E, Sadowy, E, Bigogo, G, Mucavele, H, Belabbès, H, Diawara, I, Moïsi, J, Verani, J, Keenan, J, Nair Thulasee Bhai, JN, Ndlangisa, KM, Zerouali, K, Ravikumar, KL, Titov, L, De Gouveia, L, Alaerts, M, Ip, M, de Cunto Brandileone, MC, Hasanuzzaman, M, Paragi, M, Nurse-Lucas, M, Ali, M, Elmdaghri, N, Croucher, N, Wolter, N, Porat, N, Köseoglu Eser, Ö, Akpaka, PE, Turner, P, Gagetti, P, Tientcheu, PE, Carter, PE, Mostowy, R, Kandasamy, R, Ford, R, Henderson, R, Malaker, R, Shakoor, S, Grassi Almeida, SC, Saha, SK, Doiphode, S, Madhi, SA, Devi Sekaran, S, Srifuengfung, S, Obaro, S, Clarke, SC, Nzenze, SA, Kastrin, T, Ochoa, TJ, Balaji, V, Hryniewicz, W, and Urban, Y
- Abstract
Background: Invasive pneumococcal disease remains an important health priority owing to increasing disease incidence caused by pneumococci expressing non-vaccine serotypes. We previously defined 621 Global Pneumococcal Sequence Clusters (GPSCs) by analysing 20 027 pneumococcal isolates collected worldwide and from previously published genomic data. In this study, we aimed to investigate the pneumococcal lineages behind the predominant serotypes, the mechanism of serotype replacement in disease, as well as the major pneumococcal lineages contributing to invasive pneumococcal disease in the post-vaccine era and their antibiotic resistant traits. Methods: We whole-genome sequenced 3233 invasive pneumococcal disease isolates from laboratory-based surveillance programmes in Hong Kong (n=78), Israel (n=701), Malawi (n=226), South Africa (n=1351), The Gambia (n=203), and the USA (n=674). The genomes represented pneumococci from before and after pneumococcal conjugate vaccine (PCV) introductions and were from children younger than 3 years. We identified predominant serotypes by prevalence and their major contributing lineages in each country, and assessed any serotype replacement by comparing the incidence rate between the pre-PCV and PCV periods for Israel, South Africa, and the USA. We defined the status of a lineage as vaccine-type GPSC (≥50% 13-valent PCV [PCV13] serotypes) or non-vaccine-type GPSC (>50% non-PCV13 serotypes) on the basis of its initial serotype composition detected in the earliest vaccine period to measure their individual contribution toward serotype replacement in each country. Major pneumococcal lineages in the PCV period were identified by pooled incidence rate using a random effects model. Findings: The five most prevalent serotypes in the PCV13 period varied between countries, with only serotypes 5, 12F, 15B/C, 19A, 33F, and 35B/D common to two or more countries. The five most prevalent serotypes in the PCV13 period varied between countries, with
- Published
- 2019